Novo Nordisk shares slump as weight-loss drug trial data disappoints

Obesity drug CagriSema misses goal of 25% body weight reduction

Dec 20, 2024 - 12:00
 0  0
Novo Nordisk shares slump as weight-loss drug trial data disappoints
Obesity drug CagriSema misses goal of 25% body weight reduction

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow